Haploidentical Hematopoietic Stem Cell Transplantation (HSCT) for Patients With Severe Sickle Cell Disease

NCT04207320 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Study terminated by PI

Conditions

Sickle Cell Disease

Interventions

DEVICE: αβ+ T-cell depletion with Miltenyi CliniMACS system

Sponsor

University of Chicago